- Q2 2024 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 13, 2024$2.77 (+8.20%)Earnings
- Q1 2024 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$3.69 (+9.82%)Earnings
- Q4 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 26, 2024$3.75 (-11.76%)Earnings
- Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptNov 13, 2023$2.03 (+6.84%)Earnings
- Acumen Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q2 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023$7Earnings
- Acumen Pharmaceuticals, Inc. - Special Call TranscriptJul 17, 2023
- Acumen Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$5.73 (+18.14%)Earnings
- Q4 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 27, 2023$4.21 (+7.40%)Earnings
- Q2 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 15, 2022$5.41 (+0.19%)Earnings
- Q1 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022Earnings
Q1 2023 Acumen Pharmaceuticals Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Acumen Pharma Q1 2023 Conference Call and Webcast. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to Alex Braun, Head of Investor Relations.
Thanks, Joe. Good morning, and welcome to the Acumen conference call to discuss our business update and the financial results for the quarter ended March 31, 2023. With me today are Daniel O'Connell, our Chief Executive Officer; Dr. Eric Siemers, our Chief Medical Officer; and Matt Zuga, our Chief Financial Officer and Chief Business Officer.
Before we begin, we encourage listeners to go to the Investors section of the Acumen website to find a press release issued this morning and a related slide presentation that we'll discuss today. Please note that during today's conference call, we may make forward-looking statements within the meaning of the Federal Securities Laws, including statements concerning our financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)